eGFR — estimated glomerular filtration rate — is the most important number in kidney medicine. It is the metric nephrologists use to stage chronic kidney disease, track its progression, guide treatment decisions, and determine when kidney replacement therapy is needed. Yet most patients have never heard of it until they see it printed on a lab report, often without explanation.
Understanding what is eGFR, what your number means, and why it changes over time gives you one of the most powerful tools available for protecting kidney health. This guide explains the eGFR test in plain terms, covers what different values signal, and describes why the trend over time matters more than any single reading.
What eGFR Measures
The kidneys filter approximately 200 liters of blood every day, removing metabolic waste products, excess electrolytes, and fluid, and returning clean blood to circulation. The rate at which the kidneys perform this filtration — measured in milliliters of blood filtered per minute per 1.73 square meters of body surface area — is the glomerular filtration rate, or GFR.
In healthy adults, GFR typically ranges from 90 to 120 mL/min/1.73m². As kidney disease progresses and functioning nephrons are lost, GFR declines. The “estimated” in eGFR reflects the fact that true GFR is difficult to measure directly without infusing an exogenous substance (such as inulin or iohexol) into the bloodstream. This gold-standard measured GFR is accurate but expensive and impractical for routine clinical use.
Instead, eGFR uses serum creatinine — a waste product of normal muscle metabolism that the kidneys filter at a predictable rate — alongside age and sex to estimate GFR mathematically. Most clinical laboratories report eGFR as “>60” without specifying a precise number above that threshold, because the mathematical equations used are less accurate at higher values. A report that says “>60” is generally reassuring but does not tell you whether your GFR is 70 or 110.
How eGFR Is Calculated
The equation most widely used to calculate eGFR is the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equation. The current 2021 version removed race as a variable — a significant change from the prior 2009 version, which used a race coefficient that has since been criticized for potentially delaying CKD diagnosis in Black patients. The current CKD-EPI equation uses three inputs: serum creatinine level, age, and sex.
Creatinine is central to the calculation because it is a reliable proxy for kidney filtration — produced at a relatively constant rate by muscles, filtered freely by the glomeruli, and not significantly reabsorbed. When the kidneys slow down, creatinine accumulates in the blood. A higher serum creatinine, after accounting for age and sex, produces a lower estimated eGFR.
In situations where creatinine is unreliable — such as in patients with very high or very low muscle mass, vegetarians, or those on medications that affect creatinine secretion — cystatin C provides a better marker. Cystatin C is a protein produced at a constant rate by all nucleated cells and filtered freely by the kidneys, independent of muscle mass. The combined equation using both creatinine and cystatin C (eGFRcr-cys) is the most accurate eGFR estimate currently available.
What Your eGFR Number Means
The KDIGO (Kidney Disease: Improving Global Outcomes) classification system uses eGFR to define CKD stages, labeled G1 through G5. You do not need to memorize these numbers — your care team will interpret them in context — but knowing the framework helps you understand what your doctor means when they discuss your kidney stage.
G1 — eGFR ≥90: Normal or high filtration. G1 alone does not indicate CKD — it requires the presence of other markers of kidney damage, such as persistent proteinuria or hematuria.
G2 — eGFR 60–89: Mildly decreased filtration, again requiring a kidney damage marker for CKD diagnosis. Most patients in this range have no symptoms and are identified only through routine testing.
G3a — eGFR 45–59 and G3b — eGFR 30–44: Mildly to moderately and moderately to severely decreased kidney function. This is where clinical management becomes active: blood pressure targets tighten, nephrotoxic medications are adjusted, dietary consultations begin, and nephrology referral becomes appropriate.
G4 — eGFR 15–29: Severely decreased. This is the stage of preparation for kidney replacement therapy — whether hemodialysis, peritoneal dialysis, or kidney transplantation.
G5 — eGFR <15: Kidney failure. The kidneys cannot sustain life without replacement therapy at this level.
Why eGFR Trend Matters More Than a Single Number
A single eGFR reading, while informative, does not tell the whole story. First, confirmation requires time: CKD is defined as kidney damage or eGFR below 60 persisting for three months or longer. An eGFR of 52 on one occasion might reflect a transient insult — dehydration, an NSAID for back pain, a recent CT scan — rather than chronic disease. When a low eGFR appears for the first time, the clinical response is to repeat testing, not to immediately diagnose CKD.
Second, the rate of change predicts the future. An eGFR of 45 that has been stable for five years is usually much less worrying than one that has dropped from 70 to 45 in just 12 months. Rapid progression — a sustained decline of more than 5 mL/min/1.73m² per year — signals that underlying disease is active, that current treatments are insufficient, or that a new insult has occurred. It triggers closer monitoring and often nephrology referral.
Natural age-related GFR decline averages approximately 1 mL/min/1.73m² per year after age 40. An eGFR of 70 at age 40 might be 50 by age 60 in a person with no kidney disease — simply from normal nephron aging. Understanding this baseline trajectory helps contextualize what is truly pathological versus what is expected.
Factors That Can Make eGFR Misleading
Because eGFR relies on creatinine as a GFR proxy, any factor that alters creatinine production or elimination independent of kidney function will skew the result.
High muscle mass produces more creatinine, raising the serum creatinine level and making eGFR appear lower than the true GFR. Bodybuilders and athletes may have eGFR readings that underestimate actual kidney function. In these patients, cystatin C-based eGFR is more reliable.
Low muscle mass has the opposite effect — less creatinine production means a falsely elevated eGFR. Elderly patients, those with significant weight loss, and patients with muscle-wasting conditions may appear to have better kidney function than they actually do. Drug doses calculated from a falsely reassuring eGFR can be dangerously high.
Diet affects serum creatinine transiently. Cooked red meat contains creatine that is converted to creatinine after ingestion, raising serum creatinine for several hours. Vegetarians tend to have lower serum creatinine baselines, potentially overestimating eGFR.
Medications that block tubular creatinine secretion — trimethoprim (an antibiotic) and cimetidine (a stomach acid reducer) — cause creatinine to accumulate in the blood and eGFR to fall without any actual change in kidney filtration. This drug effect is predictable and reversible.
eGFR and Medication Safety
One of the most practical reasons to know your eGFR is that it determines whether your medications are safe at their current doses. As kidney function declines, the kidneys lose the ability to clear drugs and their metabolites, and doses appropriate at normal eGFR accumulate to toxic levels in kidney disease.
- Metformin: reduce dose at eGFR 30–45; contraindicated below 30 due to lactic acidosis risk
- NSAIDs (ibuprofen, naproxen): avoid in CKD — suppress prostaglandins that dilate renal afferent arterioles, directly reducing GFR
- IV iodinated contrast: significant nephropathy risk below eGFR 30; pre-hydration is essential
- Novel oral anticoagulants (apixaban, rivaroxaban, dabigatran): each has specific dose reduction or avoidance thresholds in CKD
- Nitrofurantoin (for UTIs): ineffective and toxic below eGFR 45
Communicating your eGFR to every prescribing provider — including urgent care clinicians and radiologists — is one of the most important self-protective actions a CKD patient can take. See the guide on kidney health numbers every adult should know for a broader overview of the values worth tracking.
eGFR Combined with Albuminuria: The Complete Risk Picture
eGFR alone captures only one dimension of kidney health — filtration capacity. The second dimension is whether the kidney’s filtering barrier is leaking protein into the urine. The urine albumin-to-creatinine ratio (ACR) measures this, and together with eGFR, it defines the full KDIGO risk framework.
The ACR is classified into three categories: A1 (normal, ACR <30 mg/g), A2 (moderately increased, ACR 30–300 mg/g), and A3 (severely increased, ACR >300 mg/g). The KDIGO heat map combines eGFR stage with ACR category to assign risk from green (low) through yellow and orange to red (highest). A patient with eGFR 65 but ACR >300 mg/g has a higher risk of progression than a patient with eGFR 45 and ACR <30 mg/g. Both must be evaluated together. See the article on albumin-to-creatinine ratio for a detailed explanation of ACR testing.
Who Should Get an eGFR Test
eGFR is measured from a standard blood draw — it does not require special preparation beyond your doctor’s usual instructions. The following groups should have eGFR checked regularly:
- Diabetes — annually, because diabetic nephropathy can be silent for years before eGFR declines
- Hypertension — annually; high blood pressure is the second most common cause of kidney failure
- Age over 60 — age-related nephron loss accelerates after 60
- Family history of CKD or kidney failure
- Obesity, cardiovascular disease, autoimmune disease (lupus, vasculitis)
- Prior episode of acute kidney injury — AKI survivors have significantly elevated lifetime CKD risk
For people in any of these categories, eGFR testing paired with a urine albumin-to-creatinine ratio provides the earliest possible warning of kidney disease — before any symptoms develop. See what is chronic kidney disease for context on what happens as eGFR declines over time.
Conclusion
eGFR is a number that tells you how well your kidneys are doing their most essential job. A normal eGFR is reassuring; a declining eGFR is a call to action. Knowing your number, understanding what stage it places you in, and tracking how it changes over time gives you and your healthcare team the information needed to act before kidney damage becomes irreversible.
Ask for your eGFR at your next routine blood draw. Know whether it is stable or trending. If you have diabetes, hypertension, or a family history of kidney disease, treat it as important a health metric as your blood pressure or cholesterol. The earlier a problem is detected — through the creatinine blood test and eGFR — the more options remain available to slow it down. For additional information, see high blood pressure as a kidney warning sign.
eGFR in Special Populations: Children, Pregnant Women, and the Elderly
The standard CKD-EPI equation is validated for adults aged 18 and older. In pediatric patients, different equations are used — most commonly the Bedside Schwartz equation, which incorporates height and serum creatinine to estimate GFR in children and adolescents. The physiology of kidney filtration in children is fundamentally the same as in adults, but GFR values are expressed per 1.73 m² of body surface area to standardize for body size, and normal values in children vary by age, reaching adult levels around late adolescence.
In pregnant women, kidney physiology changes substantially. GFR increases by 40 to 65 percent during the first trimester due to increased cardiac output and renal plasma flow, and remains elevated throughout most of pregnancy. This means that creatinine values that would be normal in a non-pregnant adult may actually represent impaired kidney function during pregnancy. The normal creatinine in pregnancy is approximately 0.4 to 0.8 mg/dL — lower than the non-pregnant reference range. A creatinine of 1.0 mg/dL, which would be unremarkable in a non-pregnant adult, may indicate significant kidney impairment in a pregnant woman. For this reason, standard eGFR equations are not validated in pregnancy, and clinical assessment of kidney function during pregnancy requires interpretation by a clinician familiar with these physiological changes.
In older adults, declining muscle mass — a process called sarcopenia — reduces creatinine production and lowers serum creatinine. This can mask genuine GFR decline by artificially elevating the calculated eGFR. An 80-year-old with a serum creatinine of 0.9 mg/dL and an eGFR of 65 may have meaningfully less kidney function than a 40-year-old with the same values, because the elderly patient’s lower muscle mass produces less creatinine to begin with. Cystatin C-based eGFR is particularly valuable in this age group because it is independent of muscle mass and tends to be more accurate than creatinine-based calculations in the elderly. When eGFR and cystatin C diverge significantly in an older patient, the combined eGFRcr-cys is recommended for clinical decision-making.
eGFR and Kidney Transplant Recipients
Kidney transplant recipients have a unique eGFR context that requires careful interpretation. The transplanted kidney is a single organ performing the filtration work that two kidneys once shared — and it may have come from a donor with different baseline kidney health, age, and anatomy. eGFR in transplant recipients is monitored at every clinic visit because even small, sustained declines may represent early rejection, calcineurin inhibitor toxicity (a side effect of immunosuppressive drugs), BK virus nephropathy, or recurrence of the original kidney disease in the new organ.
Target eGFR ranges after transplant vary by the time since transplant, donor characteristics, and individual factors, but a stable eGFR in the 50 to 70 mL/min/1.73m² range is considered a good functional outcome for many recipients — considerably lower than the normal range in a person with two native kidneys, but representing adequate filtration for daily life. What matters most is stability: a transplant recipient whose eGFR is holding at 55 for several years has a very different prognosis than one whose eGFR is declining at 5 mL/min/year from an initial post-transplant value of 65.
Any unexplained decline in eGFR of more than 10 mL/min/1.73m² in a transplant recipient within a few months is typically evaluated with a kidney biopsy to identify the cause — rejection, medication toxicity, or other pathology — because early identification and treatment of reversible causes can rescue a transplant that would otherwise fail. This illustrates the broader principle that eGFR is not merely a number to note, but a dynamic signal that guides clinical action when it changes.
How Often Should eGFR Be Checked?
The frequency of eGFR monitoring depends on your current kidney function and the conditions that place your kidneys at risk. The KDIGO guidelines provide a monitoring frequency framework tied to eGFR stage and albuminuria category — the same heat map described earlier. At low risk (G1-G2 with A1 albuminuria and no risk factors), annual monitoring is appropriate. At moderate risk (G3a with A1, or G1-G2 with A2), testing every six to twelve months is recommended. At high or very high risk (G3b-G4 with any albuminuria, or any stage with A3), testing every three to six months is standard, and specialist nephrology involvement is typically ongoing.
For people without CKD who are being screened because of risk factors — diabetes, hypertension, family history — annual eGFR as part of the routine metabolic panel is generally appropriate. Annual testing creates a baseline and catches the earliest deviations before they have progressed significantly. The guide on kidney health numbers every adult should know includes eGFR among the values that define kidney health and explains when changes warrant follow-up, which complements the staging framework described in this article.
What to Do When Your eGFR Is Low: Practical Next Steps
Receiving a low eGFR result for the first time can be alarming, but a single abnormal reading is rarely a reason for immediate panic. The appropriate response depends on how low the value is, whether it is new or has been present previously, and what else is happening clinically. Here is a practical framework for what to do when an eGFR result comes back below normal.
If your eGFR is between 45 and 59 (G3a) on a first measurement, the standard next step is to repeat the creatinine and eGFR in two to three months. This confirms whether the result is persistent. In the meantime, review all medications with your primary care provider — particularly NSAIDs, which should be discontinued if being used regularly, and any nephrotoxic antibiotics. Ensure blood pressure is at goal (typically below 130/80 mmHg in patients with CKD). Request a urine albumin-to-creatinine ratio to determine whether proteinuria is also present. If the low eGFR is confirmed on the repeat test and albuminuria is detected, nephrology referral is appropriate.
If your eGFR is below 30 (G4) on a first measurement or is declining rapidly — more than 5 mL/min/1.73m² per year from a prior result — seek nephrology evaluation promptly rather than waiting for the routine repeat window. An eGFR below 30 requires active preparation for kidney replacement therapy (AV fistula creation for hemodialysis takes months to mature), dietary modification (phosphorus restriction, protein moderation), and management of CKD complications including anemia and secondary hyperparathyroidism. The article on what is chronic kidney disease explains the full spectrum of management across CKD stages and provides context for understanding what to expect as kidney function changes over time.
Most importantly: do not ignore a low eGFR result and wait for symptoms to tell you something is wrong. By the time CKD produces noticeable symptoms — fatigue, swelling, nausea, reduced urine output — kidney function has often declined to G4 or G5. The entire value of eGFR as a monitoring tool lies in its ability to detect kidney disease before symptoms appear, enabling interventions that the presence of symptoms would no longer allow to be preventive. Use the number when it is given to you — ask about it, track it, and act on it.
Understanding Your Lab Report: Where to Find eGFR
Most patients receive their lab results through an online patient portal or as a printed summary from their clinic. eGFR appears as part of the basic metabolic panel (BMP) or comprehensive metabolic panel (CMP) — the standard blood tests ordered at routine annual physicals and most medical appointments. It is typically listed alongside serum creatinine, blood urea nitrogen (BUN), electrolytes (sodium, potassium, bicarbonate), and blood glucose.
On most lab reports, eGFR appears as “eGFR” or “GFR estimated” followed by the numeric value or the threshold notation “>60.” Some reports include a reference range showing the normal threshold (typically ≥60 mL/min/1.73m²); others flag values below the reference range with an “L” (low) or “H” (high) marker. If you see an eGFR below 60 flagged on your report, bring it to your provider’s attention at your next visit — or call the office sooner if the value is below 30 or has dropped significantly from a prior result. The creatinine blood test, which appears on the same panel, provides complementary information that your provider will interpret alongside the eGFR; see the article on creatinine blood test explained for guidance on reading that result as well.
Sources: National Institute of Diabetes and Digestive and Kidney Diseases | National Kidney Foundation | Mayo Clinic — Kidney Function Tests
I have been reading about what is egfr? kidney function test for weeks and this is the most thorough guide I found. I especially valued the explanation of why these recommendations exist, not just what they are. Forwarding this to others in my support group who are dealing with similar issues.
This breakdown of what is egfr? kidney function test is exactly what patients need before a specialist appointment. The article answered questions I didn’t even know I had until I started reading. Shared this with three friends who are dealing with related issues. Very useful resource.
I have been reading about what is egfr? kidney function test for weeks and this is the most thorough guide I found. It is refreshing to see an article that acknowledges individual variation rather than one-size-fits-all advice. This is exactly why I prefer this website over generic health platforms.